Trademark: 97139738
Word
MTAC
Status
Pending
Status Code
731
Status Date
Wednesday, June 19, 2024
Serial Number
97139738
Mark Type
4
Filing Date
Tuesday, November 23, 2021
Published for Opposition
Tuesday, April 11, 2023

Trademark Owner History
Avilar Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of immunoglogical, neurological, and metabolic diseases mediated by extracellular proteins

Trademark Events
Nov 26, 2021
New Application Entered
Nov 29, 2021
New Application Office Supplied Data Entered
Sep 3, 2022
Assigned To Examiner
Sep 6, 2022
Non-Final Action Written
Sep 6, 2022
Non-Final Action E-Mailed
Sep 6, 2022
Notification Of Non-Final Action E-Mailed
Mar 3, 2023
Teas Response To Office Action Received
Mar 3, 2023
Correspondence Received In Law Office
Mar 3, 2023
Teas/Email Correspondence Entered
Mar 8, 2023
Approved For Pub - Principal Register
Apr 11, 2023
Published For Opposition
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 4, 2023
Sou Teas Extension Received
Dec 4, 2023
Sou Extension 1 Filed
Dec 4, 2023
Sou Extension 1 Granted
Dec 6, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 6, 2023
Noa E-Mailed - Sou Required From Applicant
May 6, 2024
Sou Extension 2 Filed
May 6, 2024
Sou Teas Extension Received
May 6, 2024
Teas Request To Divide Received
Jun 10, 2024
Case Assigned To Intent To Use Paralegal
May 6, 2024
Teas Statement Of Use Received
Jun 20, 2024
Sou Extension 2 Granted
Jun 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 10, 2024
Case Assigned To Intent To Use Paralegal
Jun 20, 2024
Divisional Request Received
Jun 20, 2024
Divisional Processing Complete

Trademark Alertz updated from USPTO on 2030-01-24